Latest News

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

NULL Read More ​ NULL NULL  Moneycontrol Latest News Read More   NULL

What is really happening is the rebalancing of the world as European and American hegemony dwindles away Read More ​ What is really happening is the rebalancing of the world as European and American hegemony dwindles away What is really happening… और पढ़ें »The myth of the ‘Asian century’

In a statement here, the company said it received certification for Meropenem 500mg, Meropenem 1000mg, Meropenem 2000mg, Oxaliplatin 5mg/ml, Paclitaxil 6mg/ml, Cisplatin 1mg/ml, Imipenem/Cilastatin 500mg/500mg of Carbapenem. Read More ​ In a statement here, the company said it received certification for… और पढ़ें »Venus Remedies gets GMP certification from Ukraine for Carbapenem, oncology facilities in HP

The share touched a 52-week high of Rs 263.55 and a 52-week low of Rs 145 on May 31, 2023 and February 8, 2023, respectively. Read More ​ The share touched a 52-week high of Rs 263.55 and a 52-week low… और पढ़ें »Venus Remedies share price gains on GMP Certification from Ukraine

The research house has stuck to its “outperformâ€� rating with target price of Rs 460 a share, saying it sees higher volumes and market share gains Read More ​ The research house has stuck to its “outperformâ€� rating with target price… और पढ़ें »Delhivery gains as Macquarie remains bullish on higher volumes

With the aim of organising themselves into an industry association, several online bond platforms got together on June 6 to hold preliminary discussions on forming such an entity. Read More ​ With the aim of organising themselves into an industry association,… और पढ़ें »Online bond platforms coming together to form an industry association